| Radiogenomics to characterize regional genetic heterogeneity in glioblastoma LS Hu, S Ning, JM Eschbacher, LC Baxter, N Gaw, S Ranjbar, J Plasencia, ... Neuro-oncology 19 (1), 128-137, 2017 | 225 | 2017 |
| Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas JL Boxerman, CC Quarles, LS Hu, BJ Erickson, ER Gerstner, M Smits, ... Neuro-oncology 22 (9), 1262-1275, 2020 | 174 | 2020 |
| Quantitative multimodality imaging in cancer research and therapy TE Yankeelov, RG Abramson, CC Quarles Nature Reviews Clinical Oncology 11 (11), 670-680, 2014 | 128 | 2014 |
| Magnetic resonance in the era of molecular imaging of cancer JC Gore, HC Manning, CC Quarles, KW Waddell, TE Yankeelov Magnetic resonance imaging 29 (5), 587-600, 2011 | 127 | 2011 |
| Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative … RF Barajas Jr, LS Politi, N Anzalone, H Schöder, CP Fox, JL Boxerman, ... Neuro-oncology 23 (7), 1056-1071, 2021 | 104 | 2021 |
| Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation CC Quarles, BD Ward, KM Schmainda Magnetic Resonance in Medicine: An Official Journal of the International …, 2005 | 96 | 2005 |
| New insights into tumor microstructure using temporal diffusion spectroscopy DC Colvin, TE Yankeelov, MD Does, Z Yue, C Quarles, JC Gore Cancer research 68 (14), 5941-5947, 2008 | 85 | 2008 |
| A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation CC Quarles, DF Gochberg, JC Gore, TE Yankeelov Physics in Medicine & Biology 54 (19), 5749, 2009 | 84 | 2009 |
| Comparison of dual-echo DSC-MRI-and DCE-MRI-derived contrast agent kinetic parameters CC Quarles, JC Gore, L Xu, TE Yankeelov Magnetic resonance imaging 30 (7), 944-953, 2012 | 77 | 2012 |
| Imaging amide proton transfer and nuclear overhauser enhancement using chemical exchange rotation transfer (CERT) Z Zu, J Xu, H Li, EY Chekmenev, CC Quarles, MD Does, JC Gore, ... Magnetic resonance in medicine 72 (2), 471-476, 2014 | 74 | 2014 |
| Phosphatidylinositol 3-kinase signaling determines kidney size JK Chen, K Nagai, J Chen, D Plieth, M Hino, J Xu, F Sha, TA Ikizler, ... The Journal of clinical investigation 125 (6), 2429-2444, 2015 | 73 | 2015 |
| Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch M Lepage, WC Dow, M Melchior, Y You, B Fingleton, CC Quarles, ... Molecular imaging 6 (6), 7290.2007. 00035, 2007 | 69 | 2007 |
| Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI CC Quarles, LC Bell, AM Stokes Neuroimage 187, 32-55, 2019 | 63 | 2019 |
| Assessing tumor cytoarchitecture using multiecho DSC‐MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE) NB Semmineh, J Xu, JT Skinner, J Xie, H Li, G Ayers, CC Quarles Magnetic resonance in medicine 74 (3), 772-784, 2015 | 54 | 2015 |
| Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy MN Tantawy, R Jiang, F Wang, K Takahashi, TE Peterson, D Zemel, ... BMC nephrology 13, 1-11, 2012 | 54 | 2012 |
| Multisite concordance of DSC-MRI analysis for brain tumors: results of a national cancer institute quantitative imaging network collaborative project KM Schmainda, MA Prah, SD Rand, Y Liu, B Logan, M Muzi, SD Rane, ... American Journal of Neuroradiology 39 (6), 1008-1016, 2018 | 53 | 2018 |
| Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results AG Sorace, CC Quarles, JG Whisenant, AB Hanker, JO McIntyre, ... Breast cancer research and treatment 155, 273-284, 2016 | 52 | 2016 |
| A population-based digital reference object (DRO) for optimizing dynamic susceptibility contrast (DSC)-MRI methods for clinical trials NB Semmineh, AM Stokes, LC Bell, JL Boxerman, CC Quarles Tomography 3 (1), 41, 2017 | 51 | 2017 |
| Assessment of the morphological and functional effects of the anti‐angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI CC Quarles, KM Schmainda Magnetic Resonance in Medicine: An Official Journal of the International …, 2007 | 51 | 2007 |
| Correlation between estimates of tumor perfusion from microbubble contrast‐enhanced sonography and dynamic contrast‐enhanced magnetic resonance imaging TE Yankeelov, KJ Niermann, J Huamani, DW Kim, CC Quarles, ... Journal of Ultrasound in Medicine 25 (4), 487-497, 2006 | 49 | 2006 |
Ashley StokesAssociate Professor, Barrow Neurological Institute在 barrowneuro.org 的电子邮件经过验证
